NDC 15631-0607

KALI ARSENICOSUM

Kali Arsenicosum

KALI ARSENICOSUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Potassium Arsenite Anhydrous.

Product ID15631-0607_f2a33dce-13e7-438e-a1ed-7cddcc918a9a
NDC15631-0607
Product TypeHuman Otc Drug
Proprietary NameKALI ARSENICOSUM
Generic NameKali Arsenicosum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-18
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePOTASSIUM ARSENITE ANHYDROUS
Active Ingredient Strength6 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0607-4

250 TABLET in 1 CONTAINER (15631-0607-4)
Marketing Start Date2015-12-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0607-1 [15631060701]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-6 [15631060706]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-2 [15631060702]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-5 [15631060705]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-7 [15631060707]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-4 [15631060704]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-0 [15631060700]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

NDC 15631-0607-3 [15631060703]

KALI ARSENICOSUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-18
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM ARSENITE ANHYDROUS6 [hp_X]/1

OpenFDA Data

SPL SET ID:5cef660e-b356-48b3-bdf9-14b701892259
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "KALI ARSENICOSUM" or generic name "Kali Arsenicosum"

    NDCBrand NameGeneric Name
    0220-2847Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
    0220-2850Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
    15631-0246KALI ARSENICOSUMKALI ARSENICOSUM
    15631-0607KALI ARSENICOSUMKALI ARSENICOSUM
    68428-448Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
    71919-377Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS

    © 2026 FDA.report
    This site is not affiliated with or endorsed by the FDA.